Immatics at PEGS Boston Summit 2018 (April 30-May 4), in Boston, US

| News

The PEGS Boston Summit takes place from April 30th until May 4th. The Protein Engineering Summit is one of the industry's most preeminent events that inspires accelerated biotherapeutic protein drug development. It features nearly 400 presentations by world renowned leaders from pharma, academia, and government showcasing case studies, cutting edge data, insight and perspective.

We're excited to announce that we're attending the summit and will be a part of this event. Come and join us on various speeches and posters:

 

Dr Claudia Wagner, PhD, Associate Director TCR Discovery & Validation, Immatics

May 1st, 4.55-5.25 pm: "TCR-Based immunotherapy - How to find and select the right TCR candidate"

 

Dr Harpreet Singh, President & CEO, Immatics US

May 4th, 1.40-2.10 pm: "Addressing Solid Cancers with Novel Targets and TCR-T Approaches"

 

Dr Dominik Maurer, Vice President Immunology, Immatics

date, time tba: "Development of highly potent formats of soluble bispecific T-cell receptors for targeting of tumor specific HLA ligands"

 

Dr Ajla Hrle, Senior Manager Business Development, Immatics

date, time tba: "Engineering and arming of soluble T-cell receptors for targeting of tumor specific HLA ligands"

 

We're looking forward to meeting you there. Learn more about the PEGS Boston Summit here: http://www.pegsummit.com/

 

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back